Brett Sandercock - Aug 20, 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Stock symbol
RMD
Transactions as of
Aug 20, 2021
Transactions value $
-$2,404,542
Form type
4
Date filed
8/23/2021, 07:05 PM
Previous filing
Aug 20, 2021
Next filing
Sep 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $300K +5.19K +5.78% $57.76 95K Aug 20, 2021 Direct F1
transaction RMD ResMed Common Stock Options Exercise $320K +5.54K +5.84% $57.76 101K Aug 20, 2021 Direct F1
transaction RMD ResMed Common Stock Sale -$3.02M -10.7K -10.68% $281.73 89.8K Aug 20, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -5.19K -12.75% $0.00 35.5K Aug 20, 2021 ResMed Common Stock 5.19K $57.76 Direct F1, F2
transaction RMD ResMed Common Stock Options Options Exercise $0 -5.54K -15.6% $0.00 30K Aug 20, 2021 ResMed Common Stock 5.54K $57.76 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Represents date options first became exercisable. Options vest 1/3 per year.